Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial

Autor:	Kudo, Toshihiro, Hamamoto, Yasuo, Kato, Ken, Ura, Takashi, Kojima, Takashi, Tsushima, Takahiro, Hironaka, Shuichi, Hara, Hiroki, Satoh, Taroh, Iwasa, Satoru, Muro, Kei, Yasui, Hirofumi, Minashi, Keiko, Yamaguchi, Kensei, Ohtsu, Atsushi, Doki, Yuichiro, Kitagawa, Yuko
Zdroj:	In The Lancet Oncology May 2017 18(5):631-639
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu